InvestorsHub Logo
Followers 138
Posts 23727
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Sunday, 04/23/2017 10:22:27 AM

Sunday, April 23, 2017 10:22:27 AM

Post# of 403510
From Leo via Cabel

Regarding Prurisol, progress in the clinical trial is ongoing. As shareholders have noticed on clinicaltrials.gov we are adding additional sites as some sites are not producing the number of subjects they committed to. This happens all the time in clinical trials. The trials conclusion and top line data has not changed from what was presented. We are working hard with our CRO to complete this trial as soon as possible.



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=130712675

The purpose of yesterdays presentation was for shareholders and for the Pharma industry. Digestive Disease Week is May 6-9 and we will be attending. Having and hearing a presentation on clinical data is an important part of assessing Brilacidin. Showing that in the interim results it works across 2 different diseases makes it much more impactful.



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=130712694

Good luck and GOD bless,

George
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News